Heparanase promotes myeloma progression by inducing mesenchymal features and motility of myeloma cells

about

Mechanisms of heparanase inhibitors in cancer therapy.Elevated heparanase expression is associated with poor prognosis in breast cancer: a study based on systematic review and TCGA data.

P2860

Q30244089-132207B2-DC3A-46AC-89A9-047A632A57F7 Q36339725-FEC7E44C-F278-40BD-A67B-61C016CF2A57

P2860

Heparanase promotes myeloma progression by inducing mesenchymal features and motility of myeloma cells

Item

http://www.wikidata.org/entity/Q36998235

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Heparanase promotes myeloma pr ...... and motility of myeloma cells

@en

type

Item

label

Heparanase promotes myeloma pr ...... and motility of myeloma cells

@en

prefLabel

Heparanase promotes myeloma pr ...... and motility of myeloma cells

@en

P1476

Heparanase promotes myeloma pr ...... and motility of myeloma cells

@en

P2093

Deniz Peker

http://www.w3.org/2001/XMLSchema#string

Juan Li

http://www.w3.org/2001/XMLSchema#string

Kellie M Regal

http://www.w3.org/2001/XMLSchema#string

Patrick D Rowan

http://www.w3.org/2001/XMLSchema#string

Qianying Pan

http://www.w3.org/2001/XMLSchema#string

Timothy N Trotter

http://www.w3.org/2001/XMLSchema#string

Yang Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Epithelial-mesenchymal transitions in development and disease

Soluble syndecan-1 promotes growth of myeloma tumors in vivo

Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate

Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells.

Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis.

Heparanase: a key enzyme involved in cell invasion.

Heparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKL

Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.

Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.

Curing myeloma at last: defining criteria and providing the evidence.

P304

11299-11309

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.7170

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Larry J Suva

Amjad Javed

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

293168346

http://www.w3.org/2001/XMLSchema#string

P698

26849235

http://www.w3.org/2001/XMLSchema#string

P932

4905474

http://www.w3.org/2001/XMLSchema#string

Heparanase promotes myeloma progression by inducing mesenchymal features and motility of myeloma cells

about

P2860

P2860

Heparanase promotes myeloma progression by inducing mesenchymal features and motility of myeloma cells

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932